col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Publishing House: BioInsights Publishing, Ltd.

50 Results       Page 1

 [1] 
  original article Journal Date Title Authors All Authors
1 [GO] Vaccine Insights 2026―Jun―05 From pandemic to preparedness: CEPI 3.0 and the road to the 100 Days Mission Mark Lucera
2 [GO] Vaccine Insights 2026―Apr―09 Modulation of antitumor immunity by COVID-19 mRNA vaccination: retrospective association, mechanistic evidence, and need for prospective validation Adam Grippin
3 [GO] Vaccine Insights 2026―Apr―08 Towards a coherent Nordic vision for vaccine R&D, manufacturing, and pandemic preparedness Catherine Fleck-Vidal, Mike Whelan, Ingrid Kromann, Niels Thulstrup, Katie Smith, Bjørg Dystvold Nilsson, et al. (+5)
4 [GO] Vaccine Insights 2026―Jan―19 Pioneering technological innovation and sustainability in vaccine manufacturing to ensure pandemic preparedness and global access Anca Tacu, Martina Micheletti, Stephen Morris, Brenda Parker
5 [GO] Cell and Gene Therapy Insights 2026―Jan―08 A proposed protocol of derived mesenchymal stem cells for the treatment of COVID-19 patients Vasiliki Kalodimou, Alma Reyes-Calavera
6 [GO] Vaccine Insights 2025―Dec―16 Advanced technologies enabling accessible and sustainable vaccine development and manufacturing for future pandemics June Kim, Anna Särnefält
7 [GO] Vaccine Insights 2025―Dec―16 A holistic approach to pandemic preparedness: exploring the importance of integrated advice Anja Schreijer, Tomris Cesuroglu
8 [GO] Vaccine Insights 2025―Dec―16 Pandemic preparedness and the future of RNA therapeutics: RNA readiness and response Duccio Medini
9 [GO] Vaccine Insights 2025―Dec―16 The role of African scientists in pandemic preparedness Evelyn Gitau, Uzma Alam, Caxton Murira, Linda Murungi
10 [GO] Vaccine Insights 2025―Dec―10 A career in containment: insights from the epicenter of WHO’s COVID-19 response Maria Van Kerkhove
11 [GO] Vaccine Insights 2024―May―02 Maintaining ‘warm base’ capacity for pandemic preparedness Kilian Mullett
12 [GO] Vaccine Insights 2024―Mar―14 Exploring hybrid mRNA vaccine technology for lasting immunity to COVID-19 Magnus Hoffmann
13 [GO] Vaccine Insights 2024―Mar―14 Avian influenza and the risk of pandemic Mathilde Richard
14 [GO] Vaccine Insights 2023―Sep―13 Testing in times of COVID-19: legacy & unfinished agenda Carolina Batista, Yanis Ben Amor, Onder Ergonul, Peter Figueroa, Sarah C. Gilbert, Mayda Gursel, et al. (+18)
15 [GO] Vaccine Insights 2023―Sep―13 Veterinary coronavirus vaccines: successes, challenges & lessons learned for SARS-CoV-2 control Anna Hassebroek, Xiang-Jin Meng
16 [GO] Vaccine Insights 2023―Sep―13 Unpacking the vaccine clinical trial ecosystem: implementing adaptive design, leveraging pandemic experience, & supporting resource-limited settings Sushant Sahastrabuddhe
17 [GO] Vaccine Insights 2023―Sep―07 Developing optimal pediatric COVID-19 vaccines for children younger than 12 years during an evolving pandemic Flor M Muñoz, Charu Sabharwal, Alejandra Gurtman, Emmanuel B Walter, Grant C Paulsen, Eric AF Simões, et al. (+10)
18 [GO] Vaccine Insights 2023―Sep―07 Lessons from COVID-19: how can vaccine clinical trials adapt to emerging threats? Daniel Hoft
19 [GO] Vaccine Insights 2023―Aug―08 Development of recombinant vesicular stomatitis virus vaccine platform for rapid response to Ebola and COVID-19 outbreaks Christopher Ton, Michael A Winters, Raymond Ducoat, Douglas D Richardson, Kristine Fuller, Melissa Hughes
20 [GO] Vaccine Insights 2023―Aug―08 Pandemic preparedness: the vaccine manufacturer’s perspective Jane True
21 [GO] Vaccine Insights 2023―Aug―08 Rapid manufacturing of vaccines for pandemic response & personalized cancer: parallels to leverage for common pathways to expedite clinical development? Antu K. Dey
22 [GO] Vaccine Insights 2023―Aug―08 OPENCORONA: lessons learned from a pandemic vaccine consortium Matti Sällberg, Eva-Karin Gidlund
23 [GO] Vaccine Insights 2023―Aug―02 Developing mRNA influenza vaccines in the wake of COVID-19 Raffael Nachbagauer
24 [GO] Vaccine Insights 2023―Aug―01 Vaccine supply chains: priority areas of action emerging from the COVID-19 pandemic Prashant Yadav, Carolina Batista, Ravi Anupindi, Sarah C. Gilbert, Bhavna Lall, Shmuel Shoham, et al. (+10)
25 [GO] Vaccine Insights 2023―Jan―31 Why vaccinate children against COVID-19? David C Kaslow, Carolina Batista, Maria Elena Bottazzi, Onder Ergonul, J Peter Figueroa, Mayda Gursel, et al. (+11)
26 [GO] Vaccine Insights 2023―Jan―31 Sourcing quality raw & starting materials at a reasonable cost during the pandemic Caryn Fenner
27 [GO] Vaccine Insights 2023―Jan―31 Discovery to delivery in 100 days: RNA therapeutics & their role in future pandemic preparedness Tracy Humphries
28 [GO] Vaccine Insights 2022―Aug―17 EATRIS: providing the right tools, at the right time, for vaccine development in a pandemic David Morrow, Lucia Gabriele, Antonio Andreu, Florence Bietrix, Anton Ussi, Jan Langermans
29 [GO] Vaccine Insights 2022―Jul―11 Vaccine development in the COVID-19 era: regulatory challenges & innovation Peter Marks, Marco Cavaleri, Carla Vinals, Adam Hacker
30 [GO] Vaccine Insights 2022―Jul―11 COVID-19 vaccine supply chain management: a LMIC perspective Darin Zehrung
31 [GO] Vaccine Insights 2022―Jul―11 COVID-19 vaccine supply chain management: a US perspective Michael Angelastro, Robert A Johnson
32 [GO] Vaccine Insights 2022―Jul―11 COVID-19: how is the pandemic changing the vaccines space? Nicholas Jackson
33 [GO] Vaccine Insights 2022―Jul―11 Guiding America through a pandemic Anthony S Fauci
34 [GO] Vaccine Insights 2022―Jul―11 Developing broadly protective strategies to protect against future pandemic threats Ralph Baric
35 [GO] Cell and Gene Therapy Insights 2022―Apr―06 Pandemic-related supply chain disruptions in cell therapy require rapid qualification for single-sourced materials John Duguid, Paul Friedman
36 [GO] Cell and Gene Therapy Insights 2022―Jan―28 Pandemic-related trends and challenges in adult donor stem cell and cord blood collection, banking, and processing Heidi Elmoazzen
37 [GO] Cell and Gene Therapy Insights 2022―Jan―17 COVID-19 vaccine approvals: key lessons for mRNA therapeutics Venkata Indurthi, PhD, Joseph Barberio, Scott Zobbi, Dr. Christoph Kröner
38 [GO] Cell and Gene Therapy Insights 2021―Oct―12 Leveraging lessons from the COVID-19 pandemic to accelerate the development and production of viral-based gene therapies Yasser Kehail
39 [GO] Cell and Gene Therapy Insights 2021―Aug―20 COVID-19 mRNA vaccine approvals: key lessons for cell & gene therapy and mRNA therapeutic development Joseph Barberio, Christoph Kröner, Venkata Indurthi, Scott Zobbi
40 [GO] Cell and Gene Therapy Insights 2021―Apr―12 Expect the unexpected: maintaining and optimizing a cell collection network during COVID-19 Amy Hines
41 [GO] Cell and Gene Therapy Insights 2021―Mar―24 Considerations for performing virtual quality audits on manufacturers of gene therapy viral vectors: an auditor’s perspective during the COVID-19 public health emergency Gary C du Moulin, PhD, MPH, RAC
42 [GO] Cell and Gene Therapy Insights 2021―Mar―23 The importance of a strong collection cell collection network during the COVID-19 pandemic Chris McClain, MBA
43 [GO] Cell and Gene Therapy Insights 2021―Jan―20 Navigating cell therapy supply chain complexities during the COVID-19 pandemic Erin Rasch
44 [GO] Cell and Gene Therapy Insights 2020―Nov―10 Managing donor collections during the COVID-19 pandemic Joy Aho
45 [GO] Cell and Gene Therapy Insights 2020―Aug―12 Targeting lung damage in COVID-19 patients with CD34+ cell therapy Douglas Losordo
46 [GO] Cell and Gene Therapy Insights 2020―Aug―12 Clinical trials in the era of Covid-19: successes, failures & ongoing challenges Sven Kili
47 [GO] Cell and Gene Therapy Insights 2020―Aug―12 Fighting a global pandemic with an army of robots Rennos Fragkoudis, Nikolaos Pantidos
48 [GO] Cell and Gene Therapy Insights 2020―Jul―16 Regulatory affairs in regen med: building trust, expediting development and navigating the impact of COVID-19 Manal Morsy
49 [GO] Cell and Gene Therapy Insights 2020―Jun―10 How will COVID-19 impact the cord blood banking sector? WOUTER VAN’T HOF
50 [GO] Cell and Gene Therapy Insights 2020―May―21 Cell therapy’s role in defeating Covid-19 Yaky Yanay
 [1] 

50 Results       Page 1



[de][en]

Last change 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.005 sec